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of three areas of current research into the etiology of the syndrome; neurophysio-
logical, biochemical, and genetic, respectively. Assessments of therapeutic interven-
tion by such clinicians as Fish, Simmons, Feighner, Frohner, and Cantwell constitute
the third section. In the final section, Cantwell presents a medical model for research
and clinical use with hyperactive children.
This book is valuable. It gives the facts as they are known today, explores the
speculations, and defines many unanswered questions that remain to be studied. The
manner of presentation is lucid and balanced. Documentation is provided by the
references at the end ofeach chapter. The index is useful.
This book is highly recommended for anyone who wants to gain both a broad




CHEMICAL AND MOLECULAR BASIS OF NERVE ACTIVITY. By David Nachmansohn
and Eberhard Neumann. Academic Press, Inc., New York, 1975. xvii, 403 pp.
$19.50.
This monograph is a restatement and updating ofthe controversial hypothesis that
Dr. Nachmansohn has vigorously maintained for over three decades. The hypothesis
is that acetylcholine (ACh) rather than being a chemical synaptic transmitter, acts
intramembraneously to control membrane conductance changes both along the axon
and at the synaptic gap. According to Dr. Nachmansohn, ACh is stored along the
axon in intramembrane sites, released upon stimulation of the nerve, acts at its
receptor within the axonal membrane to permit the inward rush ofsodium ion. Its ac-
tion is then terminated by acetylcholinesterase (AChE). Synaptic transmission is
facilitated since this action of ACh at the presynapticjunction causes the gap to be-
come sufficiently conductive to trigger the intramembrane-released ACh at the
postsynaptic membrane. Professor Nachmansohn's principle reasons for believing in
an axonal function for ACh are (1) ACh can cause depolarization when applied to the
axon, (2) inhibitors ofacetylcholinesterase (AChE) can block conduction, and (3) the
axon contains the enzymes necessary for ACh synthesis and rapid removal as well as
specific receptors. His reasons for concluding there is an intramembrane role for
ACh in synaptic transmission include (1) ACh and its analogs, when applied ex-
traneously, can produce antidromic impulses, (2) sensitive ACh receptors are
present at both the pre- and postsynaptic terminals as well as along the axon, and (3)
no one can measure ACh being released unless an AChE inhibitor is employed (a
condition which permits the measurements of ACh at certain nonsynaptic areas as
well as at terminals).
The book is composed of three parts, the first a facsimile of the monograph
published in 1959 by Professor Nachmansohn under the same title which he himself
describes as a classic in biochemical writing. It may have classic value. Itgives an ap-
preciation ofthe considerable difficulty in doing research prior to the development of
more modern techniques. It also serves as a history oftheideas and discoveries relat-
ing to the enzymes and other factors involved with the ACh system. The second part,
also written by Dr. Nachmansohn, gives an account of the developments in research
related to his theories presented in the original manuscript. Supposedly, his theoriesBOOK REVIEWS
were reevaluated to be in accord with these developments. In actuality, he in-
terpreted most new data so that they supported his theories although many of the
results clearly dispute his notions. The result is that no major changes are made. To
counter the indictments of his theory, Dr. Nachmansohn's usual reply is that existing
techniques do not provide adequate assays to resolve the problem. For example, ac-
cording to the author, the ACh system within the axon is surrounded by protective
lipid membranes and is thus inaccessible to the various agents used in attempts to
study it. Consequently, very high concentrations of ACh are required to cause depo-
larization and very high doses of AChE inhibitors are required to block conduction.
Recent developments using snake venom preparations and lipid soluble analogs of
ACh to facilitate both substrate and inhibitor access to the ACh system, have
permitted nearly complete inhibition (98.99%) of AChE within the intact axon
without a loss of conduction or excitability. Dr. Nachmansohn dismisses these ex-
periments as inconclusive because acetyl f3-methylcholine was used as substrate for
AChE, and he does not agree with the authors' experimental evidence that the
methyl analog is as good or better a substrate for this enzyme as is ACh. Professor
Nachmansohn dismisses paper after paper of evidence against his theory. Some
readers could easily be won over. The careful reader will note that not all experi-
ments unfavorable to his theory are discussed. For example, no mention is made of
the fact that hexamethonium at relatively low concentrations can reverse and abolish
the response of the nerve fiber to exogenous ACh while producing no direct effect on
the action potential. Also, he does not address the fact that tetrodotoxin can be used
to block propagated action potentials by preventing the influx on sodium ions without
affecting synaptic or neuromuscular transmission. Tetrodotoxin does not block the
actions of endogenous or exogenous ACh, and preparations treated with this poison
release ACh in response to locally applied depolarization. Additionally, there is no
proper consideration of the observation that botulinum toxin blocks ACh release.
The third section of the book, entitled "Toward a Molecular Model of Bioelec-
tricity," was written by Dr. Eberhard Neumann. This section is an attempt at an in-
tegrated interpretation of basic data well established by electrophysiological,
biochemical, and biophysical investigations. Much of the argument and assumptions
already stated in the first two sections of the book are repeated in this section. The
validity of this molecular model depends upon one's willingness to accept these
assumptions.
In summary, this book, although provocative, is outdated and often misleading.
Rather than providing an insight into the important problems implied by the title,
this book addresses itself to two major areas about which most neurobiologists, with
good reason, have other opinions. Young investigators who want to read a
comprehensive or even an introductory overview on the problems implied by the title
would find this volume very limited in scope and a rather narrow interpretation of
contemporary advances in neurobiology. For example, Dr. Nachmansohn claims
that all sympatic junctions are cholinergic; the only function of the various other
putative transmitters is to modulate in some undefined way the primary in-
tramembrane function of ACh. Thus the years of research on norepinephrine,
dopamine, y-aminobutyric acid, and various other compounds receive only a
sentence or two in the entire book. As such, it is not a good investment for a private
library.
The ideas of Professor Nachmansohn, which have frequently been published in
review articles, should be considered seriously at some time by students of the
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nervous system. He has been a beleagured champion in maintaining the inadequacy
of explaining the action potential in purely physical terms, and pointing out short-
comings of the chemical transmitter theory. His work has stimulated much research
and probably will continue to do so. For example, although few readily accept a
direct involvement of ACh in the propagation of the action potential, no one has an
adequate explanation for its presence in the axon together with the enzymes for its
synthesis and rapid degradation or its receptors. Biochemical approaches toward the
understanding ofexcitable membranes should be complementary with electrophysio-
logical approaches. Unfortunately, this book does not serve as a compendium of the




INTERNATIONAL REVIEW OF NEUROBIOLOGY, Vol. 16. Ed. by C. C. Pfeiffer and J. R.
Smythies. Academic Press, Inc., New York, 1974. vii, 364 pp. $29.50.
Sixteen years ago the editors ofthis annual review stated that their purpose was to
present a balance between basic and clinical neurobiology. This year's review is
consistent with that policy. Those chapters of a more basic nature deal with a
molecular model for a depolarization-hyperpolarization cycle using the nicotinic
receptor, anti-acetylcholine drugs, kryptopyrrole and other monopyrroles, and RNA
metabolism in the brain. All chapters are well written and impressively referenced.
The review ofanti-acetylcholine drugs does attempt to link up basic research with its
clinical correlates by discussing the behavioral effects of these drugs and their use in
the treatment of poisoning by anticholinesterase drugs. However, this interrelation-
ship between the basic and clinical sciences is not always managed so nicely. For
instance, the chapter on the pharmacology ofkryptopyrrole and other monopyrroles
seems to have been written without regard for its relationship to the chapter review-
ing the clinical manifestations ofthe porphyrias.
The last two chapters in the book review more clinical topics. Thefirst ofthese is a
comparison of the cortical functions in man and other primates. This study in com-
parative psychology uses two methods. It correlates differences in the brains of
several species with differences in their behavior, and it correlates the effects of ex-
perimentally altering the brains of several species with the effects on their behavior.
The chapter is a must for anyone attempting to bridge the gap between animal be-
havior and human behavior. The second of these chapters reviews the possible
etiologies and treatments of porphyria. The porphyrias certainly are not common
clinical entities, but they do hold much fascination for the clinician faced with a
patient having what at first appears to be a mysterious set ofsymptoms. This chapter
is excellent and is the most up-to-date and comprehensive review ofthis subject.
From my point of view, that of a clinical psychopharmacologist, the strength of
this volume lies in its lucid style and exhaustive review of each topic. The last two
chapters are clinical pearls.
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